Financial Year |
March 31 2023 |
Monetary Funds |
754,124,825.02 |
Held-for-trading Financial Assets |
164,192,000.00 |
Notes Receivable |
-- |
Accounts Receivable |
15,220,589.93 |
Advances to Suppliers |
4,013,628.48 |
Other Receivables |
119,548,498.27 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
117,402,287.52 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
3,868,538.83 |
Total Current Assets |
1,178,370,368.05 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
3,795,265.62 |
Long-term Equity Investment |
175,462,463.93 |
Investment Properties |
301,480,758.38 |
Fixed Assetes |
568,197,564.78 |
Under-construction Projects |
1,119,928.88 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
6,903,913.20 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
171,010,683.00 |
Deferred Income Tax Assets |
16,368,361.23 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,606,752,148.18 |
Total Assets |
2,785,122,516.23 |
Short-Term Loans |
100,000,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
254,004,317.08 |
Accounts Received In Advance |
7,358,819.54 |
Employee Compensation Payable |
5,351,105.09 |
Taxes Payable |
28,565,284.51 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
64,701,108.62 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
45,015,684.62 |
Other Current Liabilities |
35,494,423.01 |
Sub-Total of Current Liabilities |
819,900,483.08 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
118,254,942.25 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
344,379,060.51 |
Total Liabilities |
1,164,279,543.59 |
Paid-In Capital(Or Share Stock) |
666,000,000.00 |
Capital Surplus |
326,085,497.54 |
Surplus Reserve |
174,951,135.32 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
387,975,338.00 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,620,842,972.64 |
Owner's Equity(Stockholder's Equity) |
1,620,842,972.64 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,785,122,516.23 |